Monday, March 25, 2013
Domain Associates, a U.S. venture capital firm investing in breakthrough life sciences technologies, and Elite Consulting, consultants and financial advisors to the Chinese pharmaceutical and medical device industry, have formed a partnership to bring the most advanced healthcare products and technologies to China.
Marken, a global clinical supply chain solutions provider, has completed its new pharmaceutical depot in Beijing, China. The new facility which provides 850 square meters of GMP compliant space for temperature controlled storage as well as distribution of clinical trial supplies is co-located with the existing Marken Beijing branch office to provide a fully integrated and best in class service to clients.
Stryker, a global medical technology company, will make a voluntary general offer to acquire all shares of Hong Kong-based Trauson Holdings for $0.97 per ordinary share for a total consideration of $764 million in an all cash transaction, representing an enterprise value of approximately $685 million.
Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, and Handok Pharmaceuticals, a pharmaceutical/healthcare company in Korea, have agreed to establish a business venture in South Korea, allowing Teva to gain entrance into the Korean pharmaceutical market, currently valued at approximately $14 billion.